1
|
Moore U, de Almeida Araujo EC, Reyngoudt H, Gordish-Dressman H, Smith F, Wilson J, James M, Mayhew A, Rufibach L, Stojkovic T, Blamire A, Straub V, Carlier P, Manera JD. P.165 Clinical outcome study of dysferlinopathy: Lower limb water T2 predicts functional decline in patients with dysferlinopathy. Neuromuscul Disord 2022. [DOI: 10.1016/j.nmd.2022.07.303] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
2
|
Reyngoudt H, Smith F, Wilson I, de Almeida Araujo EC, Marty B, Baudin P, Diaz-Manera J, Rufibach L, Dressman HG, Hilsden H, Sutherland H, Querin G, Stojkovic T, Straub V, Carlier P, Blamire A. P.163 Quantitative MRI in upper limb muscle of patients with dysferlinopathy: preliminary baseline results of the natural history study Jain COS2. Neuromuscul Disord 2022. [DOI: 10.1016/j.nmd.2022.07.301] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
3
|
Reyngoudt H, Bachasson D, Hogrel J, Baudin P, Allenbach Y, Carlier P, Benveniste O, Marty B. P.93 Effect of rapamycine on quantitative MRI outcome measures in inclusion body myositis. Neuromuscul Disord 2022. [DOI: 10.1016/j.nmd.2022.07.163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
4
|
Reyngoudt H, Baudin P, Araujo E, Carlier P, Marty B. IMAGING. Neuromuscul Disord 2021. [DOI: 10.1016/j.nmd.2021.07.363] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
5
|
Lilien C, Reyngoudt H, Seferian A, Gidaro T, Annoussamy M, Chê V, Decostre V, Ledoux I, Louër JL, Guemas E, Muntoni F, Hogrel J, Carlier P, Servais L. CLINICAL RESEARCH. Neuromuscul Disord 2021. [DOI: 10.1016/j.nmd.2021.07.024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
6
|
Garnier R, Nouyrigat E, Benoit P, Goullé JP, Granon C, Manel J, Manouchehri N, Mathieu-Huart A, Nisse P, Normand JC, Ronga-Pézeret S, Roulet A, Simon F, Gabach P, Tournoud C, Augé G, Barbillon A, Boudet C, Bourgeat M, Droissart-Long A, El Balkhi S, Franchitto N, Glaizal M, Glorennec P, Gnansia E, Haufroid V, Breurec JY, Cambier P, Carlier P, Carretier J, Chanaud D, Charrière A, Clinard F, Dereure O, Kleinlogel S, Labadie M, Laporte R, Heilier JF, Javelaud B, Lefranc A, Lelièvre B, Lucas D, Marot F, Mathieu O, Nesslany F, Nikolova-Pavageau N, Nisse C, Peronnet K, Puskarczyk E, Quénel P, Rauzier-Jaoul MC, Roussel H, Sadeg N, Sapori JM, Sauvant-Rochat MP, Verdun-Esquer C, Veyer K, Villa A, Vircondelet S. Dépistage, prise en charge et suivi des personnes potentiellement surexposées à l’arsenic inorganique du fait de leur lieu de résidence. ARCH MAL PROF ENVIRO 2020. [DOI: 10.1016/j.admp.2020.06.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
7
|
de Almeida Araujo EC, Marty B, Carlier P, Baudin P, Reyngoudt H. AUTOIMMUNE MYOPATHIES. Neuromuscul Disord 2020. [DOI: 10.1016/j.nmd.2020.08.296] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
8
|
Bachasson D, Ayaz AC, Canal A, Boisserie J, Mosso J, Jean-Amans N, Carlier P, Caldas E, Reyngoudt H, Marty B, Benveniste O, Hogrel J. MUSCLE IMAGING – MRI. Neuromuscul Disord 2020. [DOI: 10.1016/j.nmd.2020.08.166] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
9
|
Reyngoudt H, Smith F, de Almeida Araujo EC, Wilson I, Torron RF, James M, Moore U, Marty B, Rufibach L, Heather H, Sutherland H, Hogrel J, Stojkovic T, Bushby K, Straub V, Carlier P, Blamire A, COS consortium JF. MUSCLE IMAGING – MRI. Neuromuscul Disord 2020. [DOI: 10.1016/j.nmd.2020.08.162] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
10
|
Fromes Y, Barthelemy I, Cauchois X, Boisserie J, Lelouer J, Marty B, Blot S, Carlier P. P.320Cardiac phenotypic expressions in female carriers of a canine model of Duchenne muscular dystrophy. Neuromuscul Disord 2019. [DOI: 10.1016/j.nmd.2019.06.434] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
11
|
Marty B, Reyngoudt H, Carlier P. P.304Ultrafast simultaneous characterization of muscle inflammation and fatty replacement in inclusion body myositis with magnetic resonance fingerprinting (MRF). Neuromuscul Disord 2019. [DOI: 10.1016/j.nmd.2019.06.418] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
12
|
James M, Smith F, Reyngoudt H, Wilson I, Mayhew A, Fernández-Torrón R, Araujo E, Stojkovic T, Blamire A, Carlier P, Straub V. P.185The clinical outcome study for dysferlinopathy: quantitative MRI and physiotherapy outcomes to capture disease progression. Neuromuscul Disord 2019. [DOI: 10.1016/j.nmd.2019.06.240] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
13
|
Chabanon A, Annoussamy M, Daron A, Péréon Y, Cances C, Vuillerot C, Goemans N, Cuisset J, Laugel V, Schara U, Gidaro T, Seferian A, Lowes L, Carlier P, Hogrel JR, Czech C, Hermosilla R, Kwaja O, Servais L. SMA CLINICAL DATA, OUTCOME MEASURES AND REGISTRIES. Neuromuscul Disord 2018. [DOI: 10.1016/j.nmd.2018.06.105] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
14
|
Marty B, Carlier P. REGISTRIES AND CARE OF NEUROMUSCULAR DISORDERS. Neuromuscul Disord 2018. [DOI: 10.1016/j.nmd.2018.06.341] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
15
|
|
16
|
Hogrel J, Annoussamy M, Chabanon A, Daron A, Péréon Y, Cances C, Vuillerot C, Goemans N, Cuisset J, Laugel V, Schara U, Gargaun E, Gidaro T, Seferian A, Turk S, Hermosilla R, Fournier E, Baudin P, Carlier P, Servais L, Study Group. SMA CLINICAL DATA, OUTCOME MEASURES AND REGISTRIES. Neuromuscul Disord 2018. [DOI: 10.1016/j.nmd.2018.06.116] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
17
|
Bachasson D, Mosso J, Marty B, Carlier P, Hogrel JY. FSHD / OPMD / EDMD / DMI. Neuromuscul Disord 2018. [DOI: 10.1016/j.nmd.2018.06.409] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
18
|
Koumakou C, Landon-Cardinal O, Granger B, Vautier M, Reyngoudt H, Rigolet A, Champtiaux N, Guillaume-Jugnot P, Hervier B, Carlier P, Benveniste O, Allenbach Y. IRM musculaire corps entier au cours des myopathies nécrosantes auto-immunes : involution graisseuse sévère axiale et pelvi-fémorale. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.03.368] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
19
|
Abstract
An exciting, fast moving and promising field remains the use of plasma-free synthetic medium for platelet storage (10, 11), that along with the potential for getting more plasma for therapeutic needs, might also improve the quality of stored platelets. Addition of acetate to solution, may be the way to obtain these results. An astonishing fact is that citrate remains the only anticoagulant for platelet collection, and remains as well the only real cause of donor disconfort during thrombocytapheresis.
Collapse
Affiliation(s)
- M. Valbonesi
- Immunohematology Services, San Martino University Hospital, Genova - Italy
| | - R. Frisoni
- Immunohematology Services, San Martino University Hospital, Genova - Italy
| | - G. Florio
- Immunohematology Services, San Martino University Hospital, Genova - Italy
| | - M.R. Ruzzenenti
- Immunohematology Services, San Martino University Hospital, Genova - Italy
| | - P. Carlier
- Immunohematology Services, San Martino University Hospital, Genova - Italy
| |
Collapse
|
20
|
Valbonesi M, Florio G, Lercari G, Carlier P, Ruzzenenti M, Frisoni R. Plasma Exchange: The Cost/benefit Ratio and the Critical Revision of Indications. Int J Artif Organs 2018. [DOI: 10.1177/039139889301605s37] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
The number of conditions that can benefit from Plasma-Exchange (PE) continues to grow. We have recently added to the list the Cyclosporin-A induced hypertrygliceridemia and myoglobinuric acute renal insufficiency. Such as any therapeutic measure for PE, four evolutive phases can be recognized: the discovery and research, the confirmation of indications, the routine applications and the decline, when new more powerful tools are offered by culture or technology. We have participated in the first three phases during the last 20 years. Not necessarily all experiences were favourable. Nonetheless, we feel that, for the time being, a hemapheresis unit is an absolute necessity for a medium - sized hospital even if only therapeutic procedures are carried out. The phase four, decline of interest and applications, cannot be foreseen. Finally the ability of PE to shorten substantially the length of hospital stays along with the ease with which procedure can be performed on ambulatory patients, substantiate a favourable cost/benefit ratio for this therapeutic modality.
Collapse
Affiliation(s)
- M. Valbonesi
- Immunohematology Division, San Martino Hospital, Genova - Italy
| | - G. Florio
- Immunohematology Division, San Martino Hospital, Genova - Italy
| | - G. Lercari
- Immunohematology Division, San Martino Hospital, Genova - Italy
| | - P. Carlier
- Immunohematology Division, San Martino Hospital, Genova - Italy
| | - M.R. Ruzzenenti
- Immunohematology Division, San Martino Hospital, Genova - Italy
| | - R. Frisoni
- Immunohematology Division, San Martino Hospital, Genova - Italy
| |
Collapse
|
21
|
Valbonesi M, Florio G, Pungolino E, Ruzzenenti M, Carlier P, Berta S, Magnano E. RBC Aliquot Collection as a Method for Collecting, Storing and Issuing Multiple Aliquots of PRBC for Pediatric Transfusion. Int J Artif Organs 2018. [DOI: 10.1177/039139889601901010] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Affiliation(s)
- M. Valbonesi
- Immunohematology Services, San Martino University Hospital, Genova - Italy
| | - G. Florio
- Immunohematology Services, San Martino University Hospital, Genova - Italy
| | - E. Pungolino
- Immunohematology Services, San Martino University Hospital, Genova - Italy
| | - M.R. Ruzzenenti
- Immunohematology Services, San Martino University Hospital, Genova - Italy
| | - P. Carlier
- Immunohematology Services, San Martino University Hospital, Genova - Italy
| | - S. Berta
- Immunohematology Services, San Martino University Hospital, Genova - Italy
| | - E. Magnano
- Immunohematology Services, San Martino University Hospital, Genova - Italy
| |
Collapse
|
22
|
Abstract
The extensive application of IOBS has permitted a great reduction in the use of homoglous transfusion which presently represents the largest field of application of autologous systems. In cardiac and vascular surgery, IOBS is particularly useful to the goal of preventing the transmission of viral disorders and other adverse effects related to homologous transfusions. The apparatuses for IOBS may also be used to perform hemodilution and sequestration of a desired amount of platelet rich plasma. The appropriate usage of drugs in perioperative period and the promotion of hemostasis with IOBS are important costituents for the correct transfusional management of the patient. The feasibility and safety of IOBS is known and in expert hands it is an optimal method for the transfusional treatment of surgical patients
Collapse
Affiliation(s)
- M. Valbonesi
- Immunohematology Services, San Martino University Hospital, Genova - Italy
| | - P. Carlier
- Immunohematology Services, San Martino University Hospital, Genova - Italy
| | - G. Florio
- Immunohematology Services, San Martino University Hospital, Genova - Italy
| | - F. Morelli
- Immunohematology Services, San Martino University Hospital, Genova - Italy
| | - M.R. Ruzzenenti
- Immunohematology Services, San Martino University Hospital, Genova - Italy
| |
Collapse
|
23
|
Abstract
Patients with extremely high triglyceride levels and associated lipemia are at high risk for acute pancreatitis. Two factors can increase triglyceride-rich lipoproteins; one is overproduction and other is a defect in clearance. Either mechanism can cause hypertriglyceridemia and both may exist simultaneously. Causes can be either primary or secondary. Plasmapheresis is efficacious for severe hypertryceridemia in patients who have not responded to previous therapies. We have treated 15 cases of hypertrygliceridemia complicating the course of patients receiving Cyclosporin A after bone marrow transplantation. Five patients were treated with plasmapheresis, the other ten with cascade filtration. The removal rate for triglycerides was 58.0% for patients treated by cascade filtration and 63.5% for patients treated by plasmapheresis. The removal rates for triglycerides were low possibly as a consequence of early saturation of the filter.
Collapse
Affiliation(s)
- G Giannini
- Department of Immunohematology, Immunohematology Services, S. Martino University Hospital, Genova--Italy.
| | | | | | | | | | | | | |
Collapse
|
24
|
Abstract
Rheopheresis has met an increasing interest and application in different disease conditions affecting microcirculation. Its last applications are for the management of Macular and Cochlear disorders. The sudden hearing loss syndrome is a condition that affects 20 out of 100000 persons per year, reduces the patient's social interaction and quality of life. It is associated with vascular and coagulation risk factors and it is considered as a result of local hypoperfusion secondary both to inflammatory and dysimmune conditions determining inadequate NO release and endothelial dysfunction. Rheopheresis treatment is a new approach which brings to satisfactory clinical results. Cascade filtration, heparin induced lipid precipitation and conventional plasma exchange are equally effective, and only 2 sessions are required for producing long lasting benefits. Our experience is with 60 patients, 90% of which getting from partial to complete recovery after treatment as measured by pure tone audiometry.
Collapse
Affiliation(s)
- M Valbonesi
- Department of Immunohematology, San Martino University Hospital, Genova, Italy.
| | | | | | | |
Collapse
|
25
|
Benveniste O, Hogrel J, Annoussamy M, Rigolet A, Hervier B, Carlier P, Allenbach Y. Premiers résultats prometteurs de l’essai rapamycine versus placebo pour le traitement de la myosite à inclusions (RAPAMI). Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.10.360] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
26
|
Marty B, Toussaint M, Gilles R, Wahbi K, Carlier P. Skeletal muscle tissue characterization of a large cohort of patients with Becker muscular dystrophy using quantitative NMR imaging. Neuromuscul Disord 2017. [DOI: 10.1016/j.nmd.2017.06.125] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
27
|
Marty B, Coppa B, Baudin P, Carlier P. Effects of water compartmentation and distribution on skeletal muscle T1 values assessed by quantitative NMR imaging. Neuromuscul Disord 2017. [DOI: 10.1016/j.nmd.2017.06.126] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
28
|
Kolkovsky AL, Marty B, Coppa B, Giacomini E, Carlier P. Dynamic assessment of muscle perfusion, deoxymyoglobin and phosphorylated metabolites concentrations through fast interleaved NMR acquisitions with a clinical 3T scanner. Neuromuscul Disord 2017. [DOI: 10.1016/j.nmd.2017.06.551] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
29
|
Chabanon A, Annoussamy M, Daron A, Pereon Y, Cances C, Vuillerot C, Goemans N, Cuisset J, Laugel V, Schara U, Gargaun E, Gidaro T, Seferian A, Lowes L, Carlier P, Hogrel J, Czech C, Hermosilla R, Khwaja O, Servais L. Longitudinal data of the European prospective natural history study of patients with type 2 and 3 spinal muscular atrophy. Neuromuscul Disord 2017. [DOI: 10.1016/j.nmd.2017.06.154] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
30
|
Martins-Bach A, Araujo E, Matot B, Fromes Y, Baudin P, Richard I, Carlier P. Nuclear magnetic resonance relaxometry characterization of D2-mdx mice. Neuromuscul Disord 2017. [DOI: 10.1016/j.nmd.2017.06.120] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
31
|
Bachiri M, Mouvier G, Carlier P, Dubois J. Evaluation quantitative des effets de substituants sur les premiers potentiels d'ionisation de composés monofonctionnels aliphatiques. ACTA ACUST UNITED AC 2017. [DOI: 10.1051/jcp/1980770899] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
|
32
|
Smith F, Azzabou N, Reyngoudt H, Wilson I, Fernandez-Torrón R, Carlier P, Blamire A, Bushby K, Straub V. Quantitative magnetic resonance imaging of the skeletal muscle in a multi-center dysferlinopathy study: 1-year follow-up. Neuromuscul Disord 2017. [DOI: 10.1016/s0960-8966(17)30245-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
33
|
Minne E, Carlier P, Peters C, Mommaert C, Kennes C, Cortenbosch G, Schmitz F, Van Haesendonck M, Schrayen V, Wertelaers A. Belgian class II nuclear facilities such as irradiators and accelerators: Regulatory Body attention points and operating experience feedback. KERNTECHNIK 2016. [DOI: 10.3139/124.110722] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Abstract
The aim of this paper is to present the Regulatory Body attention points and the operating experience feedback from Belgian “class IIA” facilities such as industrial and research irradiators, bulk radionuclides producers and conditioners. Reinforcement of the nuclear safety and radiation protection has been promoted by the Federal Agency for Nuclear Control (FANC) since 2009. This paper is clearly a continuation of the former paper [1] presenting the evolution in the regulatory framework relative to the creation of Bel V, the subsidiary of the FANC, and to the new “class IIA” covering heavy installations such as those mentioned above. Some lessons learnt are extracted from the operating experience feedback based on the events declared to the authorities. Even though a real willingness to meet the new safety requirements is observed among the “class IIA” licensees, promoting the safety culture, the nuclear safety and radiation protection remains an endless challenge for the Regulatory Body.
Collapse
Affiliation(s)
- E. Minne
- Bel V , Rue Walcourt, 148, B-1070 Brussels , Belgium
| | - P. Carlier
- Federal Agency for Nuclear Control , Rue Ravenstein, 36, B-1000 Brussels , Belgium
| | - C. Peters
- Bel V , Rue Walcourt, 148, B-1070 Brussels , Belgium
| | - C. Mommaert
- Bel V , Rue Walcourt, 148, B-1070 Brussels , Belgium
| | - C. Kennes
- Bel V , Rue Walcourt, 148, B-1070 Brussels , Belgium
| | | | - F. Schmitz
- Bel V , Rue Walcourt, 148, B-1070 Brussels , Belgium
| | | | - V. Schrayen
- Federal Agency for Nuclear Control , Rue Ravenstein, 36, B-1000 Brussels , Belgium
| | - A. Wertelaers
- Federal Agency for Nuclear Control , Rue Ravenstein, 36, B-1000 Brussels , Belgium
| |
Collapse
|
34
|
Gerhalter T, Martins-Bach A, Baudin P, Marty B, Schoewel V, Spuler S, Carlier P. High fat infiltration and increased muscle T2 measured by 1H-NMR in a new dysferlinopathy murine model. Neuromuscul Disord 2016. [DOI: 10.1016/j.nmd.2016.06.063] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
35
|
Gidaro T, Le Louer J, Ollivier G, Duchene D, Baudin P, Marty B, Decostre V, Reyngodt H, Hogrel J, Behin A, Carlier P, Servais L. ClinBio-GNE: A longitudinal clinical, functional and imaging evaluation of patients affected by GNE myopathy. Neuromuscul Disord 2016. [DOI: 10.1016/j.nmd.2016.06.302] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
36
|
Paradas C, Moore U, James M, Mayhew A, Azzabou N, Fernandez Torron R, Reyngoudt H, Smith F, Harris E, Bettinson K, Hilsden H, Jacobs M, Feng J, Cnaan A, Rufibach L, Eagle M, Blamire A, Carlier P, Bushby K. Clinical outcome study for dysferlinopathy: One-year follow-up. Neuromuscul Disord 2016. [DOI: 10.1016/j.nmd.2016.06.029] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
37
|
Donfut AL, Lemaitre J, Walle HVD, Holbrechts S, Carlier P, Winanf C, Lebrun1 E. Primitive Pulmonary “Malignant Epithelioid Hemangioendothelioma” versus Epithelioid Angiosarcoma A Case Report and Review of the Literature. Acta Chir Belg 2016. [DOI: 10.1080/00015458.2014.11680998] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- A.-L. Donfut
- Department of Visceral Surgery, Brussels, Belgium
| | - J. Lemaitre
- Department of Visceral Surgery, Brussels, Belgium
| | - H. Van de Walle
- Department of Histopathology, Center Morpho-Pathologic, Brussels, Belgium
| | | | - P. Carlier
- Department of Visceral Surgery, Brussels, Belgium
| | - C. Winanf
- Department of Radiology, Hospital Ambroise Pare, Mons, Belgium
| | - E. Lebrun1
- Department of Visceral Surgery, Brussels, Belgium
| |
Collapse
|
38
|
Deconinck N, Richard P, Allamand V, Behin A, Lafôret P, Ferreiro A, de Becdelievre A, Ledeuil C, Gartioux C, Nelson I, Carlier RY, Carlier P, Wahbi K, Romero N, Zabot MT, Bouhour F, Tiffreau V, Lacour A, Eymard B, Stojkovic T. Bethlem myopathy: long-term follow-up identifies COL6 mutations predicting severe clinical evolution. J Neurol Neurosurg Psychiatry 2015; 86:1337-46. [PMID: 25535305 DOI: 10.1136/jnnp-2013-307245] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/15/2013] [Accepted: 12/03/2014] [Indexed: 11/04/2022]
Abstract
OBJECTIVE Mutations in one of the 3 genes encoding collagen VI (COLVI) are responsible for a group of heterogeneous phenotypes of which Bethlem myopathy (BM) represents the milder end of the spectrum. Genotype-phenotype correlations and long-term follow-up description in BM remain scarce. METHODS We retrospectively evaluated the long-term clinical evolution, and genotype-phenotype correlations in 35 genetically identified BM patients (23 index cases). RESULTS Nineteen patients showed a typical clinical picture with contractures, proximal weakness and slow disease progression while 11 presented a more severe evolution. Five patients showed an atypical presentation, namely a limb girdle muscle weakness in 2 and a congenital myopathy pattern with either no contractures, or only limited to ankles, in 3 of them. Pathogenic COL6A1-3 mutations were mostly missense or in frame exon-skipping resulting in substitutions or deletions. Twenty one different mutations were identified including 12 novel ones. The mode of inheritance was, autosomal dominant in 83% of the index patients (including 17% (N=4) with a de novo mutation), recessive in 13%, and undetermined in one patient. Skipping of exon 14 of COL6A1 was found in 35% of index cases and was mostly associated with a severe clinical evolution. Missense mutations were detected in 39% of index cases and associated with milder forms of the disease. CONCLUSIONS Long-term follow-up identified important phenotypic variability in this cohort of 35 BM patients. However, worsening of the functional disability appeared typically after the age of 40 in 47% of our patients, and was frequently associated with COL6A1 exon 14 skipping.
Collapse
Affiliation(s)
- N Deconinck
- Department of Neurology, Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles, Bruxelles, Belgium AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Centre de référence des maladies neuromusculaires, Paris Est, France
| | - P Richard
- AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, U.F. Cardiogénétique et Myogénétique Moléculaire et Cellulaire, Paris, France UMR_S 1166 Equipe "Génomique et Physiopathologie des Maladies Cardiovasculaires", Sorbonne Universités, UPMC Univ Paris 06, Institute of Cardiometabolism and Nutrition (ICAN), Paris, France
| | - V Allamand
- Sorbonne Universités, UPMC Univ Paris 06, Institut de Myologie, Paris, France CNRS, UMR7215, Paris, France Inserm, U974, Paris, France
| | - A Behin
- AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Centre de référence des maladies neuromusculaires, Paris Est, France Groupe Hospitalier Pitié-Salpêtrière, Institut de Myologie, Paris, France
| | - P Lafôret
- AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Centre de référence des maladies neuromusculaires, Paris Est, France Groupe Hospitalier Pitié-Salpêtrière, Institut de Myologie, Paris, France
| | - A Ferreiro
- AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Centre de référence des maladies neuromusculaires, Paris Est, France Sorbonne Universités, UPMC Univ Paris 06, Institut de Myologie, Paris, France Inserm U787, Paris, France
| | - A de Becdelievre
- AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, U.F. Cardiogénétique et Myogénétique Moléculaire et Cellulaire, Paris, France
| | - C Ledeuil
- AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, U.F. Cardiogénétique et Myogénétique Moléculaire et Cellulaire, Paris, France
| | - C Gartioux
- Sorbonne Universités, UPMC Univ Paris 06, Institut de Myologie, Paris, France CNRS, UMR7215, Paris, France Inserm, U974, Paris, France
| | - I Nelson
- Sorbonne Universités, UPMC Univ Paris 06, Institut de Myologie, Paris, France CNRS, UMR7215, Paris, France Inserm, U974, Paris, France
| | - R Y Carlier
- AP-HP, Service de Radiologie, Hôpital Raymond Poincaré, Garches, France
| | - P Carlier
- Groupe Hospitalier Pitié-Salpêtrière, Institut de Myologie, Paris, France
| | - K Wahbi
- AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Centre de référence des maladies neuromusculaires, Paris Est, France Sorbonne Universités, UPMC Univ Paris 06, Institut de Myologie, Paris, France CNRS, UMR7215, Paris, France Inserm, U974, Paris, France
| | - N Romero
- AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Centre de référence des maladies neuromusculaires, Paris Est, France Groupe Hospitalier Pitié-Salpêtrière, Institut de Myologie, Paris, France
| | - M T Zabot
- Centre de biotechnologie cellulaire, CHU de Lyon-GH Est, Hospices Civils de Lyon, Bron, France
| | - F Bouhour
- CHU de Lyon, G-H Est, Hôpital Pierre Wertheimer, Service d'explorations fonctionnelles neurologiques, Bron, France
| | - V Tiffreau
- CHRU de Lille, Hôpital Pierre Swynghedauw, Service de médecine physique et de réadaptation, Lille, France
| | - A Lacour
- CHRU de Lille, Hôpital Roger Salengro, Clinique neurologique, Lille, France
| | - B Eymard
- AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Centre de référence des maladies neuromusculaires, Paris Est, France Groupe Hospitalier Pitié-Salpêtrière, Institut de Myologie, Paris, France
| | - T Stojkovic
- AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Centre de référence des maladies neuromusculaires, Paris Est, France Sorbonne Universités, UPMC Univ Paris 06, Institut de Myologie, Paris, France CNRS, UMR7215, Paris, France Inserm, U974, Paris, France Groupe Hospitalier Pitié-Salpêtrière, Institut de Myologie, Paris, France
| |
Collapse
|
39
|
Marty B, Gerhalter T, Araujo E, Giacomini E, Carlier P. Skeletal muscle tissue characterization by 23Na NMRS under different vascular filling conditions. Neuromuscul Disord 2015. [DOI: 10.1016/j.nmd.2015.06.395] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
40
|
Béhin A, Salort-Campana E, Wahbi K, Richard P, Carlier RY, Carlier P, Laforêt P, Stojkovic T, Maisonobe T, Verschueren A, Franques J, Attarian S, Maues de Paula A, Figarella-Branger D, Bécane HM, Nelson I, Duboc D, Bonne G, Vicart P, Udd B, Romero N, Pouget J, Eymard B. Myofibrillar myopathies: State of the art, present and future challenges. Rev Neurol (Paris) 2015; 171:715-29. [DOI: 10.1016/j.neurol.2015.06.002] [Citation(s) in RCA: 28] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2014] [Revised: 05/11/2015] [Accepted: 06/02/2015] [Indexed: 12/18/2022]
|
41
|
Gidaro T, Duchene D, Ollivier G, Decostre V, Hogrel J, Carlier P, Behin A, Servais L. Longitudinal study for GNE gene (ClinBio-GNE). Neuromuscul Disord 2015. [DOI: 10.1016/j.nmd.2015.06.342] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
42
|
Souvannanorath S, Hatem S, Becquemin M, Zraik N, Bittar R, Rigal O, Carlier R, Carlier P, Laforêt P. Exploration of muscle metabolism during exercise and muscle imaging in late-onset form of multiple acyl-coA dehydrogenase deficiency (MADD). Neuromuscul Disord 2015. [DOI: 10.1016/j.nmd.2015.06.072] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
43
|
Reyngoudt H, Baudin P, Marty B, Azzabou N, Caldas de A. Araujo E, Loureiro de Sousa P, Carlier P. Validation of a two-component EPG-model to estimate the muscle T2 water values by 1H-MRS. Neuromuscul Disord 2015. [DOI: 10.1016/j.nmd.2015.06.313] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
44
|
Marty B, Baudin P, Reyngoudt H, Azzabou N, Araujo E, Carlier P, de Sousa P. Simultaneous muscle water T2 and fat fraction mapping from NMR transverse relaxometry with stimulated echo compensation. Neuromuscul Disord 2015. [DOI: 10.1016/j.nmd.2015.06.394] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
45
|
Martins Bach A, Matot B, Wary C, Bitoun M, Vaizof M, Carlier P. Non-invasive NMR study of the mouse model for centronuclear myopathy with mutation in the dynamin-2 gene. Neuromuscul Disord 2015. [DOI: 10.1016/j.nmd.2015.06.322] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
46
|
Veldhuizen O, Campion G, Morgan A, Aygun H, Wojczewski S, Voit T, Carlier P, Verschuuren J, Aartsma - Rus A, Straub V. G.P.116. Neuromuscul Disord 2014. [DOI: 10.1016/j.nmd.2014.06.130] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
47
|
Servais L, Le Guiner C, Montus M, Cherel Y, Francois V, Thibaud J, Wary C, Matot B, Larche T, Guigand L, Dutilleul M, Goubin H, Deschamps J, Domenger C, Allais M, Le Duff J, Devaux M, Jaulin N, Guilbaud M, Adjali O, Latournerie V, Veron P, Boutin S, Leborgne C, Desgue D, Moullec S, Barnay-Toutain F, Riviere C, Delaunay N, Bonne G, Masurier C, Hogrel J, Carlier P, Moullier P, Voit T. G.P.92. Neuromuscul Disord 2014. [DOI: 10.1016/j.nmd.2014.06.106] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
48
|
Dabaj I, Quijano-Roy S, Estournet B, Eymard B, Stojkovic T, Wallgren-Pettersson C, Carlier P, Andres DG, Dore B, Malfatti E, Romero N, Carlier R. G.P.268. Neuromuscul Disord 2014. [DOI: 10.1016/j.nmd.2014.06.344] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
49
|
Mankodi A, Janiczek R, Froeling M, Azzabou N, Gaur L, Stock D, Evers R, Bishop C, Yao L, Grunseich C, Arai A, Carlier P, Fischbeck K. G.O.10. Neuromuscul Disord 2014. [DOI: 10.1016/j.nmd.2014.06.198] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
50
|
Laforêt P, Carlier R, Laloui K, Carlier P, Salort-Campana E, Pouget J, Echaniz-Laguna A. T.P.17. Neuromuscul Disord 2014. [DOI: 10.1016/j.nmd.2014.06.253] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|